This includes individuals with: Diagnosed MASLD or MASH, where GLP-1 therapy may offer therapeutic benefits but requires monitoring Chronic viral hepatitis (hepatitis B or C), particularly if transaminases are elevated Autoimmune hepatitis or other inflammatory liver conditions Cirrhosis or advanced fibrosis, where specialist consultation may be appropriate despite generally not requiring dose adjustment History of drug-induced liver injury from other agents For these patients, baseline comprehensive liver assessmentincluding liver enzymes, synthetic function tests (albumin, INR), and potentially imaging or non-invasive fibrosis markers (such as FIB-4 or ELF)helps establish a reference point for monitoring treatment effects
All treatments are available at Signature Medical Spa and tailored to your individual needs
Omzo doesn't guarantee results - and any telehealth platform that does should raise a flag
Drug facts Your care team will check in regularly to see how youre feeling and help you track your results
In ALS, GLP-1 analogues have extended survival in preclinical studies
Improving Mitochondrial Function: One lesser-known aspect of GLP-1's impact is its ability to improve mitochondrial function